Pedro Aguilar-Salinas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pedro Aguilar-Salinas has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
Eric Sauvageau
Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA
12 shared publications- Ricardo A. Hanel
Neurosurgery, Baptist Medical Center Jacksonville, Jacksonville, Florida, USA
10 shared publications - Amin Aghaebrahim
Neurological Institute, Lyerley Neurosurgery, Baptist Medical Center Jacksonville, Jacksonville, Florida, USA
9 shared publications - Roberta Santos
Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida, USA
8 shared publications - Gustavo Maldonado Cortez
Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida, USA
6 shared publications Ricardo A Hanel
Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida, USA
6 shared publications
Latest Publications
- Open Access
- 3 April 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Reports
- Vol. 86 (02) , e114-e115
Endoscopic Resection of Right Petrous Meningioma Causing Trigeminal Neuralgia: “The Double Crush” Phenomenon
Trigeminal neuralgia (TN) is typically caused by neurovascular compression (NVC) at the root entry zone, often involving the superior cerebellar artery. Occasionally, TN may be secondary to cerebellopontine angle (CPA) tumors, such as meningiomas, vestibular schwannomas, or epidermoid cysts. When both a tumor and a vascular loop contribute to nerve compression, the resulting, as we refer to the “double crush” phenomenon, complicates surgical management and necessitates a more comprehensive therapeutic strategy. Literature indicates that a simultaneous approach targeting both the tumor and the NVC is crucial to achieving optimal outcomes.Microvascular decompression (MVD) alone may be insufficient for patients with tumor-associated TN, as the residual mass effect can persist. The literature suggests that combining MVD with tumor resection provides superior pain relief and reduces recurrence rates. An endoscopic retrosigmoid craniotomy offers enhanced visualization and maneuverability, allowing complete tumor resection and effective nerve decompression with excellent clinical results.We present the case of a 55-year-old female with right-sided TN due to a petrous meningioma and an adjacent superior cerebellar artery loop compressing the trigeminal nerve. The patient underwent endoscopic tumor resection and MVD, resulting in significant pain relief and improved facial sensation. This case emphasizes the need to address both compressive etiologies in TN cases associated with CPA tumors to achieve the best clinical outcomes.
- 3 April 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Reports
- Vol. 86 (02) , e114-e115
Open AccessEndoscopic Resection of Right Petrous Meningioma Causing Trigeminal Neuralgia: “The Double Crush” Phenomenon
Trigeminal neuralgia (TN) is typically caused by neurovascular compression (NVC) at the root entry zone, often involving the superior cerebellar artery. Occasionally, TN may be secondary to cerebellopontine angle (CPA) tumors, such as meningiomas, vestibular schwannomas, or epidermoid cysts. When both a tumor and a vascular loop contribute to nerve compression, the resulting, as we refer to the “double crush” phenomenon, complicates surgical management and necessitates a more comprehensive therapeutic strategy. Literature indicates that a simultaneous approach targeting both the tumor and the NVC is crucial to achieving optimal outcomes.Microvascular decompression (MVD) alone may be insufficient for patients with tumor-associated TN, as the residual mass effect can persist. The literature suggests that combining MVD with tumor resection provides superior pain relief and reduces recurrence rates. An endoscopic retrosigmoid craniotomy offers enhanced visualization and maneuverability, allowing complete tumor resection and effective nerve decompression with excellent clinical results.We present the case of a 55-year-old female with right-sided TN due to a petrous meningioma and an adjacent superior cerebellar artery loop compressing the trigeminal nerve. The patient underwent endoscopic tumor resection and MVD, resulting in significant pain relief and improved facial sensation. This case emphasizes the need to address both compressive etiologies in TN cases associated with CPA tumors to achieve the best clinical outcomes.
- 10 July 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 232, 107877
Outcomes following therapeutic intervention of post-traumatic vasospasm: A systematic review and meta-analysis
- 10 July 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 232, 107877
Outcomes following therapeutic intervention of post-traumatic vasospasm: A systematic review and meta-analysis
- 16 June 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107836
Predictors of revision surgery after bedside subdural drain placement for chronic subdural hematomas
- 16 June 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107836
Predictors of revision surgery after bedside subdural drain placement for chronic subdural hematomas
- 12 February 2023
- Published by Elsevier in World Neurosurgery
- Vol. 173, e250-e297
Recurrence Rates Following Treatment of Spinal Vascular Malformations: A Systematic Review and Meta-Analysis
- 12 February 2023
- Published by Elsevier in World Neurosurgery
- Vol. 173, e250-e297
Recurrence Rates Following Treatment of Spinal Vascular Malformations: A Systematic Review and Meta-Analysis
- Top Cited Papers
- 1 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 111-122
Three-Dimensional Printing in Neurosurgery Residency Training: A Systematic Review of the Literature
- 1 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 111-122
Top Cited PapersThree-Dimensional Printing in Neurosurgery Residency Training: A Systematic Review of the Literature
- 1 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, e8-e17
Utility of Augmented Reality and Virtual Reality in Spine Surgery: A Systematic Review of the Literature
- 1 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, e8-e17
Utility of Augmented Reality and Virtual Reality in Spine Surgery: A Systematic Review of the Literature
- 11 February 2022
- Published by Springer Nature in Neurosurgical Review
- Vol. 45 (3) , 1951-1964
Current status of augmented reality in cerebrovascular surgery: a systematic review
Augmented reality (AR) is an adjuvant tool in neuronavigation to improve spatial and anatomic understanding. The present review aims to describe the current status of intraoperative AR for the treatment of cerebrovascular pathology. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The following databases were searched: PubMed, Science Direct, Web of Science, and EMBASE up to December, 2020. The search strategy consisted of “augmented reality,” “AR,” “cerebrovascular,” “navigation,” “neurovascular,” “neurosurgery,” and “endovascular” in both AND and OR combinations. Studies included were original research articles with intraoperative application. The manuscripts were thoroughly examined for study design, outcomes, and results. Sixteen studies were identified describing the use of intraoperative AR in the treatment of cerebrovascular pathology. A total of 172 patients were treated for 190 cerebrovascular lesions using intraoperative AR. The most common treated pathology was intracranial aneurysms. Most studies were cases and there was only a case–control study. A head-up display system in the microscope was the most common AR display. AR was found to be useful for tailoring the craniotomy, dura opening, and proper identification of donor and recipient vessels in vascular bypass. Most AR systems were unable to account for tissue deformation. This systematic review suggests that intraoperative AR is becoming a promising and feasible adjunct in the treatment of cerebrovascular pathology. It has been found to be a useful tool in the preoperative planning and intraoperative guidance. However, its clinical benefits remain to be seen.
- 11 February 2022
- Published by Springer Nature in Neurosurgical Review
- Vol. 45 (3) , 1951-1964
Current status of augmented reality in cerebrovascular surgery: a systematic review
Augmented reality (AR) is an adjuvant tool in neuronavigation to improve spatial and anatomic understanding. The present review aims to describe the current status of intraoperative AR for the treatment of cerebrovascular pathology. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The following databases were searched: PubMed, Science Direct, Web of Science, and EMBASE up to December, 2020. The search strategy consisted of “augmented reality,” “AR,” “cerebrovascular,” “navigation,” “neurovascular,” “neurosurgery,” and “endovascular” in both AND and OR combinations. Studies included were original research articles with intraoperative application. The manuscripts were thoroughly examined for study design, outcomes, and results. Sixteen studies were identified describing the use of intraoperative AR in the treatment of cerebrovascular pathology. A total of 172 patients were treated for 190 cerebrovascular lesions using intraoperative AR. The most common treated pathology was intracranial aneurysms. Most studies were cases and there was only a case–control study. A head-up display system in the microscope was the most common AR display. AR was found to be useful for tailoring the craniotomy, dura opening, and proper identification of donor and recipient vessels in vascular bypass. Most AR systems were unable to account for tissue deformation. This systematic review suggests that intraoperative AR is becoming a promising and feasible adjunct in the treatment of cerebrovascular pathology. It has been found to be a useful tool in the preoperative planning and intraoperative guidance. However, its clinical benefits remain to be seen.
- 1 May 2021
- Published by Elsevier in World Neurosurgery
- Vol. 149, e369-e377
Carotid Cavernous Fistula Treatment via Flow Diversion: A Systematic Review of the Literature
- 1 May 2021
- Published by Elsevier in World Neurosurgery
- Vol. 149, e369-e377
Carotid Cavernous Fistula Treatment via Flow Diversion: A Systematic Review of the Literature
- 11 November 2020
- Published by Springer Nature in Neuroradiology
- Vol. 63 (6) , 925-934
The use of cangrelor in neurovascular interventions: a multicenter experience
Purpose Thromboembolic events represent the most common procedure-related complication associated with neurointerventions. Cangrelor is a potent, intravenous (IV), P2Y12-receptor antagonist with a rapid onset and offset presented as an alternative antiplatelet agent. We aim to evaluate the safety and effectiveness of IV cangrelor in neurovascular intervention. Methods This is a retrospective analysis of data from four cerebrovascular interventional centers. We identified patients who underwent acute neurovascular intervention and received cangrelor as part of their optimum care. Patients were divided into 2 groups: ischemic and aneurysm. Periprocedural thromboembolic events, hemorrhagic complications, and outcomes were analyzed. Results Sixty-six patients were included, 42 allocated into the ischemic group (IG), and 24 into aneurysm group (AG). The IG periprocedural symptomatic complication rate was 9.5%, represented by 3 postoperative intracranial hemorrhages and 1 retroperitoneal hematoma. At discharge, 47.6% had a favorable outcome and the mortality rate was 2.4%, related to clinical deterioration of a large infarct. In the AG, 4.2% had a periprocedural complication during or after cangrelor infusion, represented by an intracranial hemorrhage in an initially ruptured aneurysm. Favorable clinical outcome was seen in 56.2% and 87.7% of ruptured and unruptured aneurysms, respectively, upon discharge. Conclusions Cangrelor may be a feasible alternative for patients requiring immediate intervention with the use of endoluminal devices. It allows the possibility for a secure transition to long-term ticagrelor and progression to surgery in the setting of unexpected complications.
- 11 November 2020
- Published by Springer Nature in Neuroradiology
- Vol. 63 (6) , 925-934
The use of cangrelor in neurovascular interventions: a multicenter experience
Purpose Thromboembolic events represent the most common procedure-related complication associated with neurointerventions. Cangrelor is a potent, intravenous (IV), P2Y12-receptor antagonist with a rapid onset and offset presented as an alternative antiplatelet agent. We aim to evaluate the safety and effectiveness of IV cangrelor in neurovascular intervention. Methods This is a retrospective analysis of data from four cerebrovascular interventional centers. We identified patients who underwent acute neurovascular intervention and received cangrelor as part of their optimum care. Patients were divided into 2 groups: ischemic and aneurysm. Periprocedural thromboembolic events, hemorrhagic complications, and outcomes were analyzed. Results Sixty-six patients were included, 42 allocated into the ischemic group (IG), and 24 into aneurysm group (AG). The IG periprocedural symptomatic complication rate was 9.5%, represented by 3 postoperative intracranial hemorrhages and 1 retroperitoneal hematoma. At discharge, 47.6% had a favorable outcome and the mortality rate was 2.4%, related to clinical deterioration of a large infarct. In the AG, 4.2% had a periprocedural complication during or after cangrelor infusion, represented by an intracranial hemorrhage in an initially ruptured aneurysm. Favorable clinical outcome was seen in 56.2% and 87.7% of ruptured and unruptured aneurysms, respectively, upon discharge. Conclusions Cangrelor may be a feasible alternative for patients requiring immediate intervention with the use of endoluminal devices. It allows the possibility for a secure transition to long-term ticagrelor and progression to surgery in the setting of unexpected complications.
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e86-e93
Pipeline Embolization Device for the Treatment of Intracranial Pseudoaneurysms
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e86-e93
Pipeline Embolization Device for the Treatment of Intracranial Pseudoaneurysms